Back to Search Start Over

First Evidence of Restoration of T and NK Cell Compartment after Venetoclax Treatment

Authors :
de Weerdt, Iris
Hofland, Tom
Dobber, Johan
Dubois, Julie
Eldering, Eric
Mobasher, Mehrdad
Croon-de Boer, Fransien
Hoogendoorn, Mels
Velders, Gerjo A.
van der Klift, Marjolein
Levin, Mark-David
Kersting, Sabina
Tonino, Sanne
Kater, Arnon P.
Source :
Blood; November 2018, Vol. 132 Issue: Supplement 1 p1860-1860, 1p
Publication Year :
2018

Abstract

Eldering: Celgene: Research Funding. Mobasher:F. Hoffmann-La Roche Ltd: Other: Ownership interests non-PLC; Genentech Inc: Employment. Levin:Janssen: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees. Kater:Abbvie: Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene: Research Funding; Janssen: Membership on an entity's Board of Directors or advisory committees, Research Funding; Acerta: Membership on an entity's Board of Directors or advisory committees, Research Funding; Roche/Genentech: Membership on an entity's Board of Directors or advisory committees, Research Funding.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
132
Issue :
Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs53593582
Full Text :
https://doi.org/10.1182/blood-2018-99-116283